Shares of Guided Therapeutics, Inc. (OTCMKTS:GTHP – Get Free Report) traded up 1.3% during trading on Wednesday . The company traded as high as $0.16 and last traded at $0.16. 606 shares changed hands during mid-day trading, a decline of 97% from the average session volume of 20,770 shares. The stock had previously closed at $0.16.
Guided Therapeutics Price Performance
The stock’s 50-day moving average is $0.17 and its two-hundred day moving average is $0.15. The company has a market cap of $9.88 million, a P/E ratio of -5.40 and a beta of 0.49.
About Guided Therapeutics
Guided Therapeutics, Inc, a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.
See Also
- Five stocks we like better than Guided Therapeutics
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- Using the MarketBeat Dividend Yield Calculator
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- Options Trading – Understanding Strike Price
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Guided Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guided Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
